Clinical Trial Update: A Study Evaluating ABI-H0731-containing Regimens in Chinese Participants With Chronic Hepatitis B Virus Infection [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating regimens containing ABI-H0731 in Chinese participants with chronic hepatitis B was terminated, with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B

Drugs mentioned

• ABI-H0731-containing regimens (ABI-H0731)

Snippet

Sponsor: Assembly Biosciences | Conditions: Chronic Hepatitis B | Phase 2 | Status: TERMINATED | Results posted: 2023-10-06